Literature DB >> 9246787

Trafficking of adoptively transferred B lymphocytes in B-lymphocyte-deficient mice.

R Roth1, M J Mamula.   

Abstract

Many studies have investigated the fate of adoptively transferred lymphocytes in recipient mice, although little is known of the sites where these transferred cells reside at particular time points. Using flow cytometry, we analyzed the trafficking pattern of adoptively transferred naive B cells into the lymphoid organs of syngeneic B-cell-deficient (microMT) mice. Within the first 24 h of transfer, the location of B cells was highly dependent on the mode of B-cell transfer. When B cells were injected subcutaneously into microMT mice, they showed a different trafficking pattern from cells administered into the peritoneal cavity or injected intravenously. After subcutaneous transfer into the thigh, the greatest number of B cells was detected in the popliteal lymph node nearest to the injection site, whereas the lowest number was detected in the axillary lymph node opposite to the injection side. Within the first 24 h of either intraperitoneal and intravenous injection, B cells were found in approximately equal numbers in the lymph nodes and the spleen. Two days later, the B-cell distribution in the lymphoid organs appeared to be independent of the mode of B-cell transfer. A transient decrease in the numbers of splenic and lymph node B cells occurred 9 days after B-cell transfer (a decrease from 70 to 87%) prior to the outgrowth of B cells that occurs 21 days after transfer. These studies are useful for understanding the numbers of B cells that may be required in adoptive transfer studies and their potential cellular interactions at particular physiological sites based on the route of cell transfer.

Entities:  

Mesh:

Year:  1997        PMID: 9246787     DOI: 10.1242/jeb.200.14.2057

Source DB:  PubMed          Journal:  J Exp Biol        ISSN: 0022-0949            Impact factor:   3.312


  9 in total

1.  CD4+ T cells derived from B cell-deficient mice inhibit the establishment of peripheral B cell pools.

Authors:  N Baumgarth; G C Jager; O C Herman; L A Herzenberg
Journal:  Proc Natl Acad Sci U S A       Date:  2000-04-25       Impact factor: 11.205

2.  Importance of B cells, but not specific antibodies, in primary and secondary protective immunity to the intracellular bacterium Francisella tularensis live vaccine strain.

Authors:  K L Elkins; C M Bosio; T R Rhinehart-Jones
Journal:  Infect Immun       Date:  1999-11       Impact factor: 3.441

3.  B cell mediated priming following pneumococcal colonization.

Authors:  Bradley Rabquer; Anne K Shriner; S Louise Smithson; M A Julie Westerink
Journal:  Vaccine       Date:  2006-11-28       Impact factor: 3.641

4.  Adoptive regulatory T-cell therapy preserves systemic immune homeostasis after cerebral ischemia.

Authors:  Peiying Li; Leilei Mao; Guoqing Zhou; Rehana K Leak; Bao-Liang Sun; Jun Chen; Xiaoming Hu
Journal:  Stroke       Date:  2013-10-03       Impact factor: 7.914

5.  An inactivated cell culture Japanese encephalitis vaccine (JE-ADVAX) formulated with delta inulin adjuvant provides robust heterologous protection against West Nile encephalitis via cross-protective memory B cells and neutralizing antibody.

Authors:  Nikolai Petrovsky; Maximilian Larena; Venkatraman Siddharthan; Natalie A Prow; Roy A Hall; Mario Lobigs; John Morrey
Journal:  J Virol       Date:  2013-07-17       Impact factor: 5.103

6.  Antibody-independent control of gamma-herpesvirus latency via B cell induction of anti-viral T cell responses.

Authors:  Kelly B McClellan; Shivaprakash Gangappa; Samuel H Speck; Herbert W Virgin
Journal:  PLoS Pathog       Date:  2006-06-23       Impact factor: 6.823

7.  Protective immunity to Bordetella pertussis requires both B cells and CD4(+) T cells for key functions other than specific antibody production.

Authors:  M Leef; K L Elkins; J Barbic; R D Shahin
Journal:  J Exp Med       Date:  2000-06-05       Impact factor: 14.307

8.  Hishot display--a new combinatorial display for obtaining target-recognizing peptides.

Authors:  Shoutaro Tsuji; Makiko Yamashita; Taihei Kageyama; Takashi Ohtsu; Katsuo Suzuki; Shintaro Kato; Joe Akitomi; Makio Furuichi; Iwao Waga
Journal:  PLoS One       Date:  2013-12-27       Impact factor: 3.240

9.  Enlarged colitogenic T cell population paradoxically supports colitis prevention through the B-lymphocyte-dependent peripheral generation of CD4(+)Foxp3(+) Treg cells.

Authors:  Fábio Barrozo do Canto; Sylvia Maria Nicolau Campos; Alessandra Granato; Rafael F da Silva; Luciana Souza de Paiva; Alberto Nóbrega; Maria Bellio; Rita Fucs
Journal:  Sci Rep       Date:  2016-06-29       Impact factor: 4.379

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.